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Abstract
Background: Identification of the genetic alterations responsible for human disease is a central challenge facing
medical genetics. While many algorithms have been developed to predict the degree of damage caused by a
given sequence alteration, few tools are able to incorporate information about a given phenotype of interest.
Methods: Here, we describe an algorithm and web-based application which take into account both the probability
that a variant damages the function of a gene as well as the relevance of the gene to a given phenotype.
Phenotypes are described by a list of scored terms supplied by the user. These terms are then used to search a
variety of public databases including NCBI gene summaries, PubMed abstracts, and Gene Ontology terms, and
protein-protein interactions in String-DB to determine a relevance score. The overall ranking is determined by the
product of the functional damage score and the relevance score, such that highly ranked variants are likely to be
damaging and in genes of interest.
Results: We demonstrate the method on several test cases including samples with Hereditary Hemorrhagic
Telangiectasia (HHT) and Diamond-Blackfan Anemia (DBA). We have also implemented a web-based application
which allows public access to the VarRanker algorithm.
Conclusions: Automated searching of public literature and online databases may substantially decrease the
amount of time required to identify the mutations underlying human disease. However, several ad-hoc and
subjective decisions must be made, and the results of such analyses are likely to depend on the researcher and the
state of the literature and databases involved.
Background
A fundamental challenge facing medical geneticists is the
efficient ranking and filtering of genetic sequence varia-
tions by their likelihood of association with a particular
phenotype. Newly developed high-throughput sequencing
technologies quickly identify thousands to millions of
sequence variants per sample, and while common filtering
strategies may substantially reduce this number, often
hundreds or thousands of potentially interesting variants
must be manually investigated to determine their rele-
vance to the phenotype under consideration. This process
may be very time consuming even for a single sample, and
manual examination is likely to be impractical for larger,
multi-sample studies [1].
Many algorithms have so far been developed to classify
genetic variants by their probability of causing disease
(e.g. [2][3][4]-[5]). These classification strategies utilize
multiple sources of information to determine the prob-
ability that a given variant is damaging, including
sequence conservation, the biochemical properties of
the amino acids involved, and the characteristics of
known-disease causing mutations culled from the litera-
ture. While these tools are valuable for gene discovery
studies, their usefulness is limited by several factors.
First, all individuals, including healthy individuals, bear a
large number of variants predicted to be disease-causing.
Thus, while some fraction of variants may be filtered out
because they are predicted to be benign, researchers may
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nonetheless be confronted with hundreds of damaging
variants per sample. Second, the strategies do not incor-
porate phenotypic information regarding the condition in
question and predict only the probability that a variant
disrupts the function of a protein in question, and not
whether the protein influences a particular phenotype.
Appropriate incorporation of phenotypic information
into variant classification strategies is complicated by
several factors. First, while numerous public databases
exist that contain information about genes and their
related phenotypes, the databases vary widely in the
type, quality, and update frequency of the information.
Efficiently retrieving and parsing the relevant informa-
tion from these sources represents a nontrivial technical
obstacle. Second, many options exist for gathering phe-
notypic information supplied by the user. Previously
described strategies require a disease name or set of
training genes to generate results (e.g.[6][7][8]). These
methods use a variety of similarity measures, including
sequence similarity, protein-interaction network features,
and Gene Ontology terms to identify genes with simila-
rities to the target set. Finally, converting the informa-
tion supplied by the user and that obtained from the
databases into a raw numerical score presents several
challenges, in particular how heavily to weight various
subscores and how to combine scores from disparate
measures. Overcoming these challenges is likely to
involve some ad-hoc decisions, and the algorithm’s out-
put will reflect the subjective nature of the input as well
as the current state of the databases queried. Despite
the subjective nature of such procedures many variants
may be rapidly eliminated based on their lack of associa-
tion with any term, gene, or process of interest.
Here, we propose a variant prioritization algorithm
that explicitly includes both the probability that a given
variant damages the gene’s function as well as a broad
measure of the relevance of the gene to a given pheno-
type. The product of these two orthogonal measures is
then taken as a predictor of the overall likelihood that a
given variant is responsible for some phenotype under
consideration. Phenotypic information is obtained from
four sources: NCBI gene summaries, PubMed abstracts,
Gene Ontology (G.O.) terms, and protein-protein inter-
actions. By using two largely independent measures of
relevance we show that the list of variants requiring
manual inspection may be substantially shortened, facili-
tating rapid identification of the sequence variations
underlying a given phenotype.
Methods
The algorithm combines two orthogonal measures to rank
variants. The first measure combines the scores of six dif-
ferent mutation effect prediction algorithms into a single
value that quantifies the probability that the variant
damages the function of the gene in which it resides.
We term this score the ‘functional damage score’. The
second measure examines each gene and quantifies its
relevance to a particular phenotype, where the phenotype
is described by the user using several techniques. We refer
to this score as the ‘relevance’ score. Details of both meth-
ods are described below. Each method produces a single
value quantifying the contribution of the method. The
product of the two values determines the overall rank of
a particular variant.
Quantification of functional damage
We assume that for a genetic variant to cause a disease
phenotype it must disrupt protein function in some way.
To assess the degree to which a variant disrupts protein
function we combine six previously described variant clas-
sification methods into a single score. The six scores are
SIFT [2], Polyphen-2 [3], MutationTaster [4], GERP++ [9],
PhyloP [10], LRT [11], and SiPhy [12], and we use a table
of precomputed scores for all amino-acid changing posi-
tions in the human genome described in dbNSFP2.0 [13].
The scores encompass a variety of variant classification
strategies, including evolutionary conservation, sequence
properties such as CpG content, and amino acid proper-
ties such as size and hydrophobicity. Intronic, intergenic,
and silent changes are ignored.
To combine the six measures into a single score, we
sought a linear combination of scores that produces the
maximal difference between variants known to be disease-
causing and those unlikely to cause disease. Previous
studies have shown that combining multiple prediction
algorithms can lead to greater overall sensitivity and
specificity [14][15]. To obtain a data set of known disease-
causing mutations we consulted those described in the
Human Gene Mutation Database [16], extracted only
those mutations categorized as disease causing, and disre-
garded all functional polymorphisms and variants without
support from functional studies (disease-associated
polymorphisms). The total number of disease-causing
mutations was 14,264. For the non-disease associated
mutations we extracted all SNPs at greater than 5%
frequency in the 1000 Genomes Project, Nov. 2010 release,
totalling 7,325 SNPs. For a given set of coefficients w, we
are then able to compute for any position and mutational
change a single score that is a linear combination of the
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between the disease-causing and the non-disease associated
mutations. To accomplish this we constructed an ad-hoc
function that quantified the amount of similarity in the
distributions of scores for the two data sets, as follows:
Z =
σa + σb
a¯− b¯ + c (2)
Where sa and a¯ are the standard deviation and mean of
the scores for all disease-causing mutations, respectively,
with similar nomenclature for non-disease associated
mutations, and c is a small constant (0.001) that prevents
the denominator from attaining very small values when
the mean of a and b are nearly equal. We then employed a
numerical function minimization technique to determine
the set of weights that resulted in the smallest possible Z,
which is associated with the greatest difference in means
and smallest standard deviations among both sets of var-
iants. The resulting distribution of combined scores clearly
separates the disease-causing mutations from those that
were assumed to be non-disease causing (Figure 1a).
Receiver operating characteristic (ROC) curves for the
combined score demonstrated greater sensitivity and
specificity than for any single predictor alone (Figure 1b)
and yield satisfactory false discovery rates for a given
degree specificity (Table 1).
Finally, we note that the precomputed scores available in
dbNSFP2.0 are not available for indels and do not take into
account effects of variants on mRNA splicing. We arbitra-
rily assigned a score of 25 to all frameshifting indels and 15
to all variants in splice sites, predicting that both classes of
mutations are likely to be more functionally damaging than
most SNPs. Nonframeshifting indels are given a score
equal to their length up to a maximum of 15.0.
Quantification of relevance of gene to phenotype
The second component of the algorithm quantifies the
probability that a given gene is related to a phenotype of
interest by examining and combining information from
four publicly available databases. Specifically, we exam-
ine NCBI gene summaries, Gene Ontology (G.O.) terms,
PubMed abstracts, and gene interaction networks for
information. The first three databases are obtained
directly from the NCBI, while gene interaction networks
are obtained from the STRING database (version 9.0)
[15]. Phenotypic information is provided by the user in
three forms, scored key terms, scored G.O. terms, and
genes of interest.
The scored key terms are a list of arbitrary terms asso-
ciated with a numerical score reflecting their relevance to
the phenotype, and are used to examine both gene summa-
ries and pubmed abstracts. For each NCBI gene summary
Figure 1 Combined functional damage scores for disease and non-disease associated variants. Figure 1) a) Distribution of functional
damage scores for mutations previously associated with disease (red line) and those at > 20% frequency in 1000 Genomes (blue line). b) ROC
curve for functional damage score compared to selected other predictors.
Table 1 Sensitivity and Specificity of Functional Damage
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examined (typically all genes in which a variant exists are
examined), the entire text of the summary is scanned to
determine if query term exists. If so, the score associated
with the term is added to the ‘summary score’ for that
gene. Multiple hits of the same term do not add increased
scores. The PubMed abstracts associated with a given gene
are obtained from the ‘gene2pubmed’ database maintained
by the NCBI. For each gene examined all abstracts as well
as article titles are obtained from the NCBI. All NCBI files
were obtained from ftp://ftp.ncbi.nlm.nih.gov/gene/DATA.
In a manner similar to the gene summary procedure the
entire text of the abstract as well as the title of the article is
examined for the presence of the term. If the term exists in
the abstract or summary the score associated with that
term is tallied and the total score for each abstract is com-
puted. The top-scoring abstract for each gene is then
retained as the ‘abstract score’ for the gene.
The G.O. term search procedure mirrors the gene sum-
mary procedure closely. For each gene considered G.O.
terms are obtained from NCBI databases and are scanned
for the presence of the user-supplied G.O.terms. If a
match is found, the score associated with the term is
tallied and added to the ‘G.O. Score’ for the gene.
Gene interaction information is obtained from the
STRING database [17]. Users supply a list of genes known
or strongly suspected to play a role in the phenotype of
interest, which we refer to as ‘seed genes’. These genes are
used as the query genes in a STRING database query, and
the ‘neighborhood’ of surrounding genes is obtained by
expanding the network size around the seed genes until
the network contains 500 genes. Network expansion is
accomplished by altering the ‘additional network nodes’
parameter within STRING-DB. The raw output of the
STRING procedure is a list of interactions and their asso-
ciated confidence scores. This list is converted to a graph,
where each gene is represented by a node and each inter-
action is a weighted edge. For every gene in the graph we
compute the shortest path to each of the user-supplied
query genes using Dijkstra’s algorithm. Because weights
represent stronger, not weaker, interactions, the reciprocal
of each weight is used to determine path length. The
shortest path leading to any key gene is then retained as
the final ‘interaction score’ for each gene.
The above procedure computes for each gene under
consideration four independent scores, one each for gene
summaries, PubMed abstracts, G.O. terms, and gene
interactions. The sum of these scores then represents the
total relevance of the gene to the phenotype supplied by
the user. The score is necessarily ad-hoc, and may vary
greatly by the subjective description and scores given for
each term. In addition, gene relevance scores will change
over time due to updates of gene summaries, the appear-
ance of new abstracts in PubMed, or new interactions
recorded in the STRING database.
Results
To assess the ability of our method to accurately identify
disease-causing variants we analyzed three sets of data in
which causative variants had been previously identified.
Because our method relies heavily on literature searches
and the knowledge available in public databases, we
chose data sets with differing degrees of prior knowledge,
as measured by the number of articles retrieved in
PubMed (as of August, 2012) when searching for the
name of the condition. The least well studied condition
we examine is Miller Syndrome, for which 33 citations
exist in PubMed. The most well studied data set is
Hereditary Hemorrhagic Telangiectasia (HHT, 2534
articles), and an intermediate case is Diamond-Blackfan
Anemia (DBA, 303 articles).
A. Analysis of Miller syndrome variants
Miller syndrome (also known as postaxial acrofacial dysos-
tosis, OMIM #263750), a rare autosomal genetic disorder
characterized by micrognathia, cleft lip or palate, hypopla-
sia of the posterior portions of the limbs, and colobma of
the eyelids, was one of the first disorders in which a causa-
tive gene was identified by exome sequencing [18]. Four
variants were initially uncovered by exome sequencing,
and several others identified by followup Sanger sequen-
cing in additional individuals. The causative gene was
determined to be DHODH on the basis of variant rarity,
damaged function predicted by the PolyPhen tool, and
consistent inheritance pattern across kindreds.
To determine the ability of our method to recapitulate
these known causative variants, we examine exome var-
iant sets into which the Miller syndrome variants were
added. The Miller syndrome variants represent a difficult
case for the tool described here since relatively little is
known about the pathogenesis of the disorder (excluding
[18]). Thus little phenotypic information exists to inform
a guided analysis. The absence of any previously identi-
fied genes or pathways affected in Miller syndrome pre-
cludes the use of both the G.O. term and genetic
interaction subscores. Nonetheless, to demonstrate the
flexibility of the algorithm in the face of incomplete data
we utilize only the gene summary and PubMed abstract
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subscores in our analysis. A complete listing of search
terms and scores is in supplementary table I.
To determine the ranking of the Miller syndrome
variants we spiked the variants into a control background
of exome data from the widely studied sample NA12878
(CEPH, Utah resident). The full set of input terms is listed
in supplementary material. After conducting our ranking
procedure, the seven Miller syndrome variants occupied
positions 9-14 and 17-18 out of a total of 26,670 exonic
variants, 11,969 of which were nonsynonymous, indels, or
splice-site variants. The composite gene-damaging score
was very high for all DHODH variants, ranging from 13.4 -
20.5, with scores above 20 for five of the eight variants
examined. At a cutoff of 20, the gene damage score is
greater than 98.9% of all variants in the sample for which a
score could be computed. The gene relevance score was
more moderate, however, with many non DHODH genes
associated with cleft lip and cleft palate.
B. Analysis of Hereditary Hemorrhagic Telangiectasia
sample
To demonstrate our algorithm on a case where more
complete phenotypic information is available, we exam-
ine a data set obtained from a patient with Heredity
Hemorrhagic Telangiectasia (HHT, OMIM #187300), an
autosomal dominant disorder with clinical presentation
including spontaneous recurrent epistaxis (nosebleeds),
telangiectasias, and arteriovenous malformations (AVMs)
in the brain, liver, spinal column, and lungs [19].
Mutations in the ENG, ACVRL1, and SMAD4 genes are
responsible for the disorder in some 80% of cases, but the
genetic causes are unknown in the remaining fraction.
While understanding of the molecular and cellular pro-
cesses underlying AVM formation in HHT patients is
incomplete, a substantial literature exists regarding the
mechanisms, pathways, and genes involved in angiogenesis.
Thus, ample information exists to create gene summary,
PubMed, and G.O. term lists as well as a gene interaction
network targeting the relevant genetic neighborhood.
Recently, members of our lab identified a frameshifting
2bp deletion in RASA1 (p.87_88del) in an individual pre-
senting with HHT-like symptoms. Because RASA1 muta-
tions have previously been associated with capillary and
arteriovenous malformations similar to the HHT pheno-
type ([20][21]), and because no variants were identified in
the ENG, ACVRL1, or SMAD4 genes, the RASA1 variant
was assumed to be the causative mutation for this sam-
ple. We re-analyzed this sample using our algorithm to
determine if the causative gene would be correctly identi-
fied. Variants with frequency 1% or greater among the
1000 Genomes samples were excluded. All search terms
and seed genes used as input are listed in supplementary
tables II and III.
The top five ranking variants are shown in table II. The
RASA1 variant is the overall top scoring candidate, with a
combined score roughly five times greater than the next
candidate. Frameshifting deletions are regarded as very
likely to be damaging in terms of genetic function by our
algorithm, and both gene summaries and PubMed
abstracts strongly suggest that RASA1 mutations may
have phenotypic effects similar to those found in HHT.
The very high score computed for the RASA1 variant
relative to other variants in the sample demonstrates
that, when ample prior knowledge is available, our algo-
rithm can successfully identify disease causing variants.
C. Analysis of Diamond-Blackfan anemia sample
As an additional example we examined a splice-site var-
iant in the GATA1 gene was that recently shown to
cause Diamond-Blackfan anemia (DBA, OMIM #105650)
[22]. As mentioned above, DBA an intermediate amount
of prior knowledge exists for DBA, with roughly 300 cita-
tions associated with the condition found in PubMed.
DBA is an erythroid aplasia resulting from inadequate
proliferation of erythroid progenitor cells with a popula-
tion incidence near 5 in one million live births. Previous
studies have implicated mutations in ribosomal protein
RPS19 as causing DBA in roughly 25% of cases [23][24],
and eight other ribosomal proteins have been implicated
in additional studies [25].
We were unable to access the full variant lists for the
affected individuals, so we inserted the causative muta-
tion into a variant listing from the well-studied individual
NA12878. Variants with frequency 1% or greater among
the 1000 Genomes samples were excluded, and all search
terms and seed genes used in the analysis are given in the
supplementary tables IV and V. The top five overall rank-
ing variants are given in the Table 3.
Our algorithm successfully identified the GATA1 variant
as the top-ranked variant, although the separation of the
causative variant from other variants is smaller than for
the RASA1 case. All splicing variants are arbitrarily
assigned a functional damage score of 15.0, thus the true
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Figure 2 Distribution of variant scores in HHT example case. Figure 2: Distribution of variants by functional damage score and gene
relevance score for HHT sample. Arrow indicates causative frameshift in RASA1 gene.
Figure 3 Distribution of variant scores for DBA example case. Figure 3: Distribution of variant scores for Diamond-Blackfan Anemia analysis.
Arrow indicates causative mutation in GATA1.
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variant is predicted have to fairly severe functional conse-
quences. Despite this large score, some 830 other variants
had a score as high or higher. However, the GATA1 gene
also has a very high overall relevance score, and the pro-
duct of the two relatively high scores was greater than all
other variants.
Conclusions
Our method facilitates filtering and prioritization of
genetic sequence variants by their degree of association
with a phenotype. By utilizing two orthogonal measures
of variant importance, the algorithm can significantly
reduce the number of variants requiring manual consid-
eration and thereby allow researchers to more rapidly
identify the sequence variations underlying a given dis-
ease. In addition, the algorithm’s multi- database,
search-term based approach allows for substantial flex-
ibility in terms of the phenotype associations it can
detect, and need not be employed strictly for the study
of human disease.
While we have presented several successful cases here,
the method’s ability to accurately identify causative
variants is influenced by a number of factors. Most
importantly, our method is sensitive to the state of the
literature and public databases queried, and conditions
about which relatively little is known (such as Miller
Syndrome) are less likely yield successful results with
our method. In addition, the user’s subjective choice of
input terms and their associated scores may lead to
results that differ form researcher to researcher. Finally,
our method is designed primarily for Mendelian disor-
ders, where one or a few variants of large effect are
responsible for producing the condition. Phenotypes
that are influenced by a larger number of interacting,
compensatory, or weak-effect mutations will be difficult
to analyze with the framework presented here.
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